Skip to content

Clinical trials

Phase 4 Cognition Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 4 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20071
20081
20132
20142
20151
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
HealthPartners Institute1
Intermountain Health Care, Inc.1
Kimford Jay Meador1
Nathan Kline Institute for Psychiatric Research1
National Institute on Aging (NIA)1
New York State Psychiatric Institute1
University of California, Los Angeles1
University of Iowa1
University of Maryland, Baltimore1
University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders11
Alzheimer Disease3
Schizophrenia3
Attention Deficit Disorder with Hyperactivity2
Cognitive Dysfunction2
Anosmia1
Dementia1
Epilepsy1
Neurocognitive Disorders1
Olfaction Disorders1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.